Linsley Wayne has filed 5 insider transactions across 3 companies since January 2024.
Most recent transaction: a grant/award of 5000 shares of Myseum, Inc. ($MYSE) on August 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2025 | Myseum, Inc. | $MYSE | Linsley Wayne | Director | A | Options (right to buy) | 5000 | $0.00 | 5,000.0000 | 4,209,329 | 9999.99% | 0.12% |
| May 23, 2025 | Silo Pharma, Inc. | $SILO | Linsley Wayne | Director | A | Options (right to buy) | 50000 | $0.00 | 53,425.0000 | 4,484,456 | 1459.85% | 1.12% |
| Jan. 14, 2025 | Myseum, Inc. | $MYSE | Linsley Wayne | Director | A | Options (right to buy) | 10000 | $0.00 | 17,500.0000 | 2,958,821 | 133.33% | 0.34% |
| Aug. 19, 2024 | Hoth Therapeutics, Inc. | $HOTH | Linsley Wayne | Director | A | Options | 25000 | $0.00 | 25,000.0000 | 6,876,331 | 9999.99% | 0.36% |
| Jan. 5, 2024 | Hoth Therapeutics, Inc. | $HOTH | Linsley Wayne | Director | A | Options | 25000 | $0.00 | 25,000.0000 | 3,409,190 | 9999.99% | 0.73% |